MedTrace Logo

Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients

NCT05749445 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-03-01

No results posted yet for this study

Summary

The primary objective of the study was to assess the appropriateness of antiviral therapy with nirmatrelvir-ritonavir in hospitalized patients.

Conditions

  • Hospitalized Patients

Interventions

DRUG

Nirmatrelvir-Ritonavir

Nirmatrelvir-Ritonavir

Sponsors & Collaborators

  • Hangzhou Cancer Hospital

    collaborator OTHER

  • First People's Hospital of Lin'an District

    collaborator UNKNOWN

  • First People's Hospital of Yuhang District

    collaborator UNKNOWN

  • First People's Hospital of Hangzhou

    lead OTHER

Principal Investigators

  • Changcheng Shi · First People's Hospital of Hangzhou

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-15
Primary Completion
2023-04-30
Completion
2023-04-30
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05749445 on ClinicalTrials.gov